Evaluating the potential benefit of reduced planning target volume margins for low and intermediate risk patients with prostate cancer using real-time electromagnetic tracking.

Although the initial decrements were smaller in our study, the ProtecT radiation therapy cohort showed a trend to return closer to baseline while our study showed stability/small decrements in bowel and urinary scores throughout 24 months of follow-up.

also in 53,322 other papers